0113 2727560

Contact Us

Contact CPWY

Twitter Latest Tweets

Latest PSNC News

Class 4 MHRA Drug Alert – Ativan 4mg/1ml Solution for injection (Lorazepam) (Pfizer Limited) Caution in use

Drug Alert No: EL (19) A/10 Date Issued: 24th April 2019 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 drug alert for certain batches of Ativan 4mg/1ml Solution for Injection (Lorazepam) (Pfizer Limited) Ativan 4mg/1ml Solution for Injection (Lorazepam) (Pfizer Limited) PL 00057/1279 Batch Number Expiry Date Pack Size First...

11 hours ago

April 2019 Price Concessions – 2nd update

Department of Health and Social Care (DHSC) has today granted the following list of price concessions: Drug Pack size Price Concession Betahistine 8mg tablets 84 £1.38 Betahistine 16mg tablets 84 £2.70 Candesartan 16mg tablets 28 £2.90 Carvedilol 12.5mg tablets 28 £2.10 Celecoxib 200mg capsules 30 £13.76 Diamorphine 10mg powder for solution for injection ampoules 5...

6 days ago

MHRA Drug Safety Update April 2019

Date issued: 16th April 2019 A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 9 March 2019:1) has been published and includes articles on: Yellow fever vaccine (Stamaril) and fatal adverse reactions: extreme caution needed in people who may be immunosuppressed and those 60 years and older. Valproate medicines...

8 days ago

EPS Nominations

It is important if contractors are starting to collect nominations that they are aware of:

  • No inducements can be offered for patients to nominate your pharmacy for EPS R2. This means that money, gifts, points and discounts (along with anything else that may be classed as an inducement) must not be offered or given. The LPC is aware that some contractors do currently offer inducements for signing up to Prescription Collection Services. This must not happen for EPS R2 nominations.
  • Pharmacies must have ‘local accountable auditable processes' for obtaining explicit consent. Consent cannot be assumed to have been given just because a patient is signed up to your PCS service (even if your PCS leaflets make reference to EPS). As part of this consent process there is a range of information that must be given to the patient. Connecting for Health has produced a leaflet called "Explaining the Electronic Prescription Service - Information for patients and carers in England which can be downloaded here. These leaflets can be ordered from the Department of Health's Publication Orderline by clicking here or contacting 0300 123 1002.
  • Community Pharmacy West Yorkshire has produced an EPS Nomination Form to enable you to capture consent for nomination.
  • You may find it useful to have an SOP to cover your nomination processes. Both the NPA and Numark have developed template SOPs.
  • You will not currently be notified if a patient changes their nomination. It is the most recent nomination that counts.
  • Nominations can only be made on an EPS Release 2 system and by an individual with an EPS R2 smartcard. NHS England will be able to track all nominations and will use this data to investigate any issues. You must not share your smartcard with anybody else.
  • You must be aware of the NHS England 'Nomination: what you need to know' document which can be downloaded by clicking here.